Tissue inhibitor of metalloproteinases-2 inhibits the activation of 72 kDa progelatinase by fibroblast membranes.

No abstract is available for this paper.

• Publication year

  1991

• Venue

  Biochimica et Biophysica Acta

• Publication date

  1991-08-30

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/0167-4838(91)90132-JPMID 1911847
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Matrix metalloproteinase degradation of elastin, type IV collagen and proteoglycan. A quantitative comparison of the activities of 95 kDa and 72 kDa gelatinases, stromelysins-1 and -2 and punctuated metalloproteinase (PUMP).

  1991cited by this paper
• The purification of tissue inhibitor of metalloproteinases-2 from its 72 kDa progelatinase complex. Demonstration of the biochemical similarities of tissue inhibitor of metalloproteinases-2 and tissue inhibitor of metalloproteinases-1.

  1991cited by this paper
• The tissue metalloproteinase family and the inhibitor TIMP: a study using cDNAs and recombinant proteins.

  1990cited by this paper
• Matrix metalloproteinase 2 from human rheumatoid synovial fibroblasts. Purification and activation of the precursor and enzymic properties.

  1990cited by this paper
• Extraction of type‐IV collagenase/gelatinase from plasma membranes of human cancer cells

  1990cited by this paper
• Concanavalin A produces a matrix-degradative phenotype in human fibroblasts. Induction and endogenous activation of collagenase, 72-kDa gelatinase, and Pump-1 is accompanied by the suppression of the tissue inhibitor of matrix metalloproteinases.

  1990cited by this paper
• Independent expression and cellular processing of Mr 72,000 type IV collagenase and interstitial collagenase in human tumorigenic cell lines.

  1990cited by this paper
• Tissue inhibitor of metalloproteinase (TIMP-2). A new member of the metalloproteinase inhibitor family.

  1989cited by this paper
• The activation of human type IV collagenase proenzyme. Sequence identification of the major conversion product following organomercurial activation.

  1989cited by this paper
• The role of plasminogen in cell-mediated collagen degradation.

  1989cited by this paper
• Purification and characterization of a bone metalloproteinase that degrades gelatin and types IV and V collagen.

  1985cited by this paper
• Sequence of human tissue inhibitor of metalloproteinases and its identity to erythroid-potentiating activity

  1985cited by this paper
• Purification and characterization of a rabbit bone metalloproteinase that degrades proteoglycan and other connective-tissue components.

  1983cited by this paper
• Human gingival tissues in culture synthesize three metalloproteinases and a metalloproteinase inhibitor.

  1982cited by this paper
• Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecyl sulfate and copolymerized substrates.

  1980cited by this paper
• Maturation of the head of bacteriophage T4. I. DNA packaging events.

  1973cited by this paper

• MEMBRANE-TYPE MATRIX METALLOPROTEINASES

  2017cites this paper
• Matrix Metalloproteinases and Their Inhibitors

  2015cites this paper
• Physiological Functions of Membrane‐Type Metalloproteases

  2012cites this paper
• SERIES ''MATRIX METALLOPROTEINASES IN LUNG HEALTH AND DISEASE'' Edited by J. Muller-Quernheim and O. Eickelberg Number 3 in this Series The role of matrix metalloproteinases in cystic fibrosis lung disease

  2011cites this paper
• Metalloproteinases and Their Natural Inhibitors Connective Tissue Degradation in Health and Periodontal Disease and the Roles of Matrix

  2011cites this paper
• The role of matrix metalloproteinases in cystic fibrosis lung disease

  2011cites this paper
• Matrix metalloproteinases in atherothrombosis.

  2010cites this paper
• Caracterização do perfil de expressão de MMPs e de seus inibidores, TIMPs e Reck, em linhagens representativas dos diferentes estágios de progressão do melanona humano

  2010cites this paper
• MMP and TIMP alterations in asymptomatic and symptomatic severe recurrent carotid artery stenosis.

  2009cites this paper
• STRUCTURAL INTERACTIONS BETWEEN THE Α3Β1 INTEGRIN AND MMP-2: A POTENTIAL FUNCTIONAL ROLE IN CELL ADHESION

  2009cites this paper
• Novel laminin 5 gamma 2-chain fragments potentiating the limbal epithelial cell outgrowth on amniotic membrane.

  2009cites this paper
• Interplay of angiotensin II and angiotensin(1–7) in the regulation of matrix metalloproteinases of human cardiocytes

  2008cites this paper
• Collagenases and tissue inhibitors of metalloproteinases: a functional balance in tissue degradation.

  2008cites this paper
• Bone sialoprotein binding to matrix metalloproteinase-2 alters enzyme inhibition kinetics.

  2008cites this paper
• Adenovirus‐mediated expression of TIMP‐1 and TIMP‐2 in bone inhibits osteolytic degradation by human prostate cancer

  2008cites this paper
• Collagen stiffness regulates cellular contraction and matrix remodeling gene expression.

  2007cites this paper
• Gingival Tissue and Crevicular Fluid Co-operation in Adult Periodontitis

  2006cites this paper
• Alterations in biochemical components of extracellular matrix in intervertebral disc herniation: role of MMP‐2 and TIMP‐2 in type II collagen loss

  2006cites this paper
• Effects of tissue inhibitor of metalloproteinase 2 deficiency on aneurysm formation.

  2006cites this paper
• Ovarian Carcinoma Xenografts Tumor Burden and Prolongs Survival of Mice Bearing Human A Synthetic Matrix Metalloproteinase Inhibitor Decreases Updated

  2006cites this paper
• Individual Timp Deficiencies Differentially Impact Pro-MMP-2 Activation*

  2006cites this paper
• Molecular and cellular analysis of basement membrane invasion by human breast cancer cells in Matrigel-basedin vitro assays

  2005cites this paper
• Effects of Green Tea on Matrix Metalloproteinases in Streptozotocin-induced Diabetic Rats

  2005cites this paper
• Extracellular Matrix Digestion

  2005cites this paper
• Competitive disruption of the tumor-promoting function of membrane type 1 matrix metalloproteinase/matrix metalloproteinase-14 in vivo

  2005cites this paper
• ( MMPs ) , Integrins , and Extracellular Matrix Molecules Coordinated Interactions Among Matrix Metalloproteinases − − Proteolytic Events of Wound-Healing

  2005cites this paper
• Metalloproteinases and their inhibitors are markers of plaque instability.

  2005cites this paper
• Role of Matrix Metalloproteinases in Bone Metastasis from Human Breast and Prostate Cancer

  2004cites this paper
• Green tea catechins inhibit neointimal hyperplasia in a rat carotid arterial injury model by TIMP-2 overexpression.

  2004cites this paper
• Membrane proteases as potential diagnostic and therapeutic targets for breast malignancy

  2004cites this paper
• Collagen induced MMP-2 activation in human breast cancer

  2004cites this paper
• Gelatinase A expression and localization in human breast cancers. An in situ hybridization study and immunohistochemical detection using confocal microscopy

  2004cites this paper
• Limited processing of pro-matrix metalloprotease-2 (gelatinase A) overexpressed by transfection in PC-3 human prostate tumor cells: association with restricted cell surface localization of membrane-type matrix metalloproteinase-1.

  2004cites this paper
• MATRIX METALLOPROTEINASE-2 (MMP-2) AND -9 (MMP-9) IN HEMATOLOGICAL MALIGNANCIES

  2003cites this paper
• Sequence motifs of tissue inhibitor of metalloproteinases 2 (TIMP-2) determining progelatinase A (proMMP-2) binding and activation by membrane-type metalloproteinase 1 (MT1-MMP).

  2003cites this paper
• Role of MMPs and plasminogen activators in angiogenesis after transmyocardial laser revascularization in dogs.

  2003cites this paper
• Structure and evolutionary aspects of matrix metalloproteinases: A brief overview

  2003cites this paper
• TIMP-2 (tissue inhibitor of metalloproteinase-2) regulates MMP-2 (matrix metalloproteinase-2) activity in the extracellular environment after pro-MMP-2 activation by MT1 (membrane type 1)-MMP.

  2003cites this paper
• Proteases and Their Inhibitors in Gliomas

  2002cites this paper
• Tissue Inhibitors of Metalloproteinases in Cancer

  2002cites this paper
• Altered Regulation of Matrix Metalloproteinase-2 in Aortic Remodeling During Aging

  2002cites this paper
• Expression of matrix metalloproteinase‐2 and ‐9 and their inhibitors, tissue inhibitor of metalloproteinase‐1 and ‐2, in primary cultures of human prostatic stromal and epithelial cells * †

  2002cites this paper
• Matrix Metalloproteinase Expressions in Arteriosclerotic Aneurysmal Disease

  2002cites this paper
• Proteases and Their Inhibitors in Cancer Metastasis

  2002cites this paper
• Anetoderma: An Altered Balance Between Metalloproteinases and Tissue Inhibitors of Metalloproteinases

  2002cites this paper
• Gelatinases A and B.

  2002cites this paper
• Monocyte Membrane Type 1-Matrix Metalloproteinase

  2001cites this paper
• The expression and localization of membrane type-1 matrix metalloproteinase in human abdominal aortic aneurysms.

  2001cites this paper
• Proteolytic events of wound-healing--coordinated interactions among matrix metalloproteinases (MMPs), integrins, and extracellular matrix molecules.

  2001cites this paper
• Extracellular Matrix Degradation and the Role of Hepatic Stellate Cells

  2001cites this paper
• of Membrane Type 1-Matrix Metalloproteinase Support the Activation of Gelatinase A via Efficient Inhibition Tissue Inhibitor of Metalloproteinases-4 Inhibits But Does Not Updated

  2001cites this paper
• Characterization of the Role of the “MT-loop”

  2001cites this paper
• Collagen-induced proMMP-2 activation by MT1-MMP in human dermal fibroblasts and the possible role of alpha2beta1 integrins.

  2001cites this paper
• Secretion of Gelatinases and Activation of Gelatinase A (MMP-2) by Human Rheumatoid Synovial Fibroblasts

  2001cites this paper
• Tissue inhibitor of metalloproteinases-4 inhibits but does not support the activation of gelatinase A via efficient inhibition of membrane type 1-matrix metalloproteinase.

  2001cites this paper
• Type IV collagen induces matrix metalloproteinase 2 activation in HT1080 fibrosarcoma cells.

  2000cites this paper
• Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary.

  2000cites this paper
• Liver fibrosis, the hepatic stellate cell and tissue inhibitors of metalloproteinases.

  2000cites this paper
• Localization of the Death Domain of Tissue Inhibitor of Metalloproteinase-3 to the N Terminus

  2000cites this paper
• Analysis of tissue inhibitor of metalloproteinases-2 effect on pro-matrix metalloproteinase-2 activation by membrane-type 1 matrix metalloproteinase using baculovirus/insect-cell expression system.

  2000cites this paper
• Matrix metalloproteinases in human melanoma.

  2000cites this paper
• Expression of membrane-type 1 matrix metalloproteinase in coronary vessels of allotransplanted primate hearts.

  2000cites this paper
• Xenopus laevis gelatinase B (Xmmp‐9): Development, regeneration, and wound healing

  2000cites this paper
• Membrane Type 4 Matrix Metalloproteinase (MMP17) Has Tumor Necrosis Factor-α Convertase Activity but Does Not Activate Pro-MMP2*

  2000cites this paper
• IL-1-mediated expression of membrane type matrix-metalloproteinase in rheumatoid osteoblasts.

  2000cites this paper
• Inhibition of late vein graft neointima formation in human and porcine models by adenovirus-mediated overexpression of tissue inhibitor of metalloproteinase-3.

  2000cites this paper
• Domain Interactions in the Gelatinase A·TIMP-2·MT1-MMP Activation Complex

  2000cites this paper
• Heat shock suppresses membrane type 1-matrix metalloproteinase production and progelatinase A activation in human fibrosarcoma HT-1080 cells and thereby inhibits cellular invasion.

  1999cites this paper
• Role of membrane-type matrix metalloproteinase 1 (MT-1-MMP), MMP-2, and its inhibitor in nephrogenesis.

  1999cites this paper
• Evaluation of Some Newer Matrix Metalloproteinases

  1999cites this paper
• Identification of the Tissue Inhibitor of Metalloproteinases-2 (TIMP-2) Binding Site on the Hemopexin Carboxyl Domain of Human Gelatinase A by Site-directed Mutagenesis

  1999cites this paper
• Reactive Site-modified Tissue Inhibitor of Metalloproteinases-2 Inhibits the Cell-mediated Activation of Progelatinase A*

  1999cites this paper
• Activation of Matrix Metalloproteinase-9 (MMP-9) via a Converging Plasmin/Stromelysin-1 Cascade Enhances Tumor Cell Invasion*

  1999cites this paper
• Role of membrane-type matrix metalloproteinase 1 ( MT1-MMP ) , MMP-2 , and its inhibitor in nephrogenesis

  1999cites this paper
• Tissue inhibitors of metalloproteinases: role in liver fibrosis and alcoholic liver disease.

  1999cites this paper
• Gonadotropin-releasing hormone agonist has the ability to induce increased matrix metalloproteinase (MMP)-2 and membrane type 1-MMP expression in corpora lutea, and structural luteolysis in rats.

  1999cites this paper
• Matrix metalloproteinase-2 and -9 are activated in joint diseases.

  1999cites this paper
• Membrane‐type matrix metalloproteinases

  1999cites this paper
• Furin-independent Pathway of Membrane Type 1-Matrix Metalloproteinase Activation in Rabbit Dermal Fibroblasts*

  1999cites this paper
• Enhancement of membrane-type 1-matrix metalloproteinase (MT1-MMP) production and sequential activation of progelatinase A on human squamous carcinoma cells co-cultured with human dermal fibroblasts

  1999cites this paper
• Cell-surface proteases in cancer

  1999cites this paper
• MMP-2 and TIMP-2 expression correlates with poor prognosis in cervical carcinoma--a clinicopathologic study using immunohistochemistry and mRNA in situ hybridization.

  1999cites this paper
• Tissue Inhibitor of Matrix Metalloproteinase-2 Regulates Matrix Metalloproteinase-2 Activation by Modulation of Membrane-type 1 Matrix Metalloproteinase Activity in High and Low Invasive Melanoma Cell Lines*

  1999cites this paper
• Activation of ProMMP‐9 by a Plasmin/MMP‐3 Cascade in a Tumor Cell Model: Regulation by Tissue Inhibitors of Metalloproteinases

  1999cites this paper
• Proteases New Perspectives

  1999cites this paper
• Membrane associated matrix metalloproteinases in metastasis.

  1999influential citation
• Metal loproteases in remodeling of vascular extracellular matrix

  1999cites this paper
• Expression of Membrane-Type Matrix Metalloproteinase in Rabbit Neointimal Tissue and Its Correlation with Matrix-Metalloproteinase-2 Activation

  1998cites this paper
• Cloning of murine membrane-type-1-matrix metalloproteinase (MT-1-MMP) and its metanephric developmental regulation with respect to MMP-2 and its inhibitor.

  1998cites this paper
• Inhibition of matrix metalloproteinase 2 maturation and HT1080 invasiveness by a synthetic furin inhibitor

  1998cites this paper
• Matrix metalloproteinases and metastatic cancer.

  1998cites this paper
• Increased expression of membrane-type matrix metalloproteinase and preferential localization of matrix metalloproteinase-2 to the neointima of balloon-injured rat carotid arteries.

  1998cites this paper
• The TIMP2 Membrane Type 1 Metalloproteinase “Receptor” Regulates the Concentration and Efficient Activation of Progelatinase A

  1998cites this paper
• Plasma Membrane-bound Tissue Inhibitor of Metalloproteinases (TIMP)-2 Specifically Inhibits Matrix Metalloproteinase 2 (Gelatinase A) Activated on the Cell Surface*

  1998cites this paper
• Role of tissue inhibitor of metalloproteinases-2 (TIMP-2) in regulation of pro-gelatinase A activation catalyzed by membrane-type matrix metalloproteinase-1 (MT1-MMP) in human cancer cells.

  1998cites this paper
• Tissue inhibitors of metalloproteinases, hepatic stellate cells and liver fibrosis

  1998cites this paper
• Phase I study of intraperitoneal metalloproteinase inhibitor BB94 in patients with malignant ascites.

  1998cites this paper
• Disruption of angiogenesis by PEX, a noncatalytic metalloproteinase fragment with integrin binding activity.

  1998cites this paper
• Cloning, expression, and characterization of chicken tissue inhibitor of metalloproteinase‐2 (TIMP‐2) in normal and transformed chicken embryo fibroblasts

  1998cites this paper
• SPARC/osteonectin induces matrix metalloproteinase 2 activation in human breast cancer cell lines.

  1998cites this paper